Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating ...
Diabetes Tips, News & Articles
... in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes.
Note: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
... in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes.
... in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes.
Read moreNote: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online